Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis

Morphometric and volumetric MRI changes in idiopathic intracranial hypertension

(2013) Jan Hoffmann et al.   CEPHALALGIA

Why Does Sleep Stop Migraine?

(2013) Marcelo E. Bigal et al.   Current Pain and Headache Reports

Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties

(2012) Paul J. Coleman et al.   ChemMedChem

Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial

(2012) P Hoever et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

(2012) Markus Färkkilä et al.   LANCET NEUROLOGY

Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant

(2012) W. J. Herring et al.   NEUROLOGY

Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia

(2011) Christopher J. Winrow et al.   NEUROPHARMACOLOGY

The orexin system: roles in sleep/wake regulation

(2010) Takeshi Sakurai et al.   Annals of the New York Academy of Sciences

Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant

(2010) P Hoever et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

An Analysis of Migraine Triggers in a Clinic-Based Population

(2010) Diane Andress-Rothrock et al.   HEADACHE

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology